63 articles
Aimery de Gramont
Aimery de Gramont is a French medical oncologist who created the FOLFOX and FOLFIRI regimens, led the MOSAIC and IDEA trials, and heads oncology at the Institut Hospitalier Franco-Britannique.
Alfredo Falcone
Alfredo Falcone, born in 1959 in New Jersey and based in Pisa, is an Italian medical oncologist known for developing FOLFOXIRI, a triplet chemotherapy for metastatic colorectal cancer.
Andrea Cercek
Andrea Cercek is a medical oncologist specializing in gastrointestinal cancers who leads colorectal cancer research and treatment at Memorial Sloan Kettering Cancer Center in New York.
Andrés Cervantes
Andrés Cervantes is a Spanish medical oncologist, Scientific Director of the INCLIVA institute in Valencia, who researches colorectal cancer and led ESMO as president from 2023 to 2024.
Armando Santoro
Armando Santoro is an Italian medical oncologist, director of the Cancer Center at IRCCS Humanitas Research Hospital in Rozzano, Milan, known for trials in Hodgkin lymphoma and hepatocellular carcinoma.
Atsushi Ohtsu
Atsushi Ohtsu is a Japanese medical oncologist specializing in gastrointestinal cancers, known for the 2015 RECOURSE trial of TAS-102 and gastric cancer trials RAINBOW and AVAGAST.
Axel Grothey
Axel Grothey is a German-trained medical oncologist directing gastrointestinal cancer research at West Cancer Center in Tennessee since 2018, known for the BEACON CRC and IDEA colorectal cancer studies.
Carmen J. Allegra
Carmen J. Allegra, also published as Carmen Allegra, is an American medical oncologist known for colorectal cancer research and nearly 20 years at the National Cancer Institute.
Charles G. Moertel
Charles G. Moertel (1927–1994) was an American oncologist at the Mayo Clinic in Rochester, Minnesota, whose large randomized trials changed chemotherapy for gastrointestinal cancers and disproved laetrile and vitamin C as cancer remedies.
Charles S. Fuchs
Charles S. Fuchs is an American medical oncologist specializing in gastrointestinal cancers who directed the Yale Cancer Center and led the REGARD gastric cancer trial.
Chiara Cremolini
Chiara Cremolini, born in 1984 in La Spezia, is an Italian medical oncologist and full professor at the University of Pisa who led the TRIBE trials in metastatic colorectal cancer.
Chris Twelves
Chris Twelves is a British medical oncologist and professor at the University of Leeds known for leading the X-ACT colon cancer and EMBRACE breast cancer drug trials.
Cornelis J.A. Punt
Cornelis J.A. Punt, known as Kees Punt, is a Dutch medical oncologist whose CAIRO trials through the Dutch Colorectal Cancer Group shaped colorectal cancer treatment.
David Cunningham (medical oncologist)
David Cunningham is a British medical oncologist who heads the Gastrointestinal and Lymphoma Unit at The Royal Marsden, specializing in colorectal, pancreatic, and esophageal cancer.
David P. Ryan
David P. Ryan is an American medical oncologist specializing in gastrointestinal cancers, the inaugural president of the Mass General Brigham Cancer Institute since 2025, and a Harvard Medical School professor.
David Tuveson
David A. Tuveson is an American cancer biologist and medical oncologist, director of the Cancer Center at Cold Spring Harbor Laboratory, known for the first mouse models of pancreatic cancer.
Eileen M. O’Reilly
Eileen M. O'Reilly is a medical oncologist at Memorial Sloan Kettering Cancer Center in New York, known for treating pancreatic and hepatobiliary cancers and developing KRAS-directed vaccines.
Elizabeth Smyth
Elizabeth Smyth is an Irish-trained medical oncologist at Oxford University Hospitals specializing in esophagogastric cancer; she chairs the EORTC GI Trials Group and was elected ESMO Director of Education in 2025.
Eric K. Rowinsky
Eric K. Rowinsky is an American clinical cancer researcher whose phase I and pharmacologic trials shaped the development of paclitaxel, irinotecan, erlotinib, and cetuximab, and who led drug development at ImClone Systems and Stemline Therapeutics.
Éric Raymond
Éric Raymond is a French medical oncologist who heads oncology at Hôpital Paris Saint-Joseph and led the 2011 phase 3 sunitinib trial in pancreatic neuroendocrine tumors.
Eric Van Cutsem
Eric Van Cutsem is a Belgian medical oncologist and gastroenterologist who heads the Division of Digestive Oncology at University Hospitals Leuven, known for cetuximab trials in colorectal cancer.
Eunice L. Kwak
Eunice L. Kwak is an American medical oncologist who led the 2010 phase 1 trial of crizotinib for ALK-positive lung cancer at Massachusetts General Hospital.
Filippo Pietrantonio
Filippo Pietrantonio is an Italian medical oncologist who heads gastrointestinal oncology at the Istituto Nazionale dei Tumori in Milan, known for the CodeBreaK 300 trial in KRAS G12C-mutated colorectal cancer.
Florian Lordick
Florian Lordick is a German medical oncologist specializing in gastro-esophageal cancer who directs the University Cancer Center Leipzig, led the 2025 ESOPEC trial, and chairs ESMO's gastric cancer guideline group.
Fortunato Ciardiello
Fortunato Ciardiello, born in Naples in 1960, is an Italian medical oncologist and professor at the University of Campania whose work established RAS mutation testing before anti-EGFR therapy in colorectal cancer.
Frank A. Sinicrope
Frank A. Sinicrope is a gastrointestinal medical oncologist and Professor of Medicine and Oncology at Mayo Clinic in Rochester, Minnesota, known for work on Lynch syndrome colorectal cancer and immunotherapy biomarkers.
Gary K. Schwartz
Gary K. Schwartz, also known as Gary Schwartz, is an American medical oncologist who directs the Case Comprehensive Cancer Center at Case Western Reserve University, specializing in sarcoma and melanoma drug development.
George D. Demetri
George D. Demetri is an American medical oncologist who directs the Sarcoma Center at Dana-Farber Cancer Institute and developed kinase-inhibitor therapies for gastrointestinal stromal tumors.
Hans‐Joachim Schmoll
Hans-Joachim Schmoll is a German medical oncologist who led cancer research at Hannover and Halle, developed colorectal cancer treatments, and wrote ESMO consensus guidelines, winning the 2020 ESMO Award.
Heikki Joensuu
Heikki Joensuu (born 1956) is a Finnish oncologist and cancer researcher, professor at the University of Helsinki from 1994 to 2019, known for the FinHer breast cancer trial and adjuvant imatinib trials in GIST.